Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta
The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical...
Saved in:
Published in | Journal of neurochemistry Vol. 103; no. 5; pp. 2092 - 2101 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Oxford, UK : Blackwell Publishing Ltd
01.12.2007
Blackwell Publishing Ltd Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical neurons. Exposure to oligomeric amyloid beta (Aβ) 1-42 peptide induced neuronal damage revealed by increased staining with fluorojade, and toxicity assessed by LDH release. Aβ-dependent neuronal death did not involve neuronal expression of the inducible nitric oxide synthase 2 (NOS2), since Aβ did not induce nitrite production from neurons, LDH release was not reduced by co-incubation with NOS2 inhibitors, and neurotoxicity was similar in wildtype and NOS2 deficient neurons. Co-incubation with NA partially reduced Aβ-induced neuronal LDH release, and completely abrogated the increase in fluorojade staining. Treatment of neurons with NA increased expression of γ-glutamylcysteine ligase, reduced levels of GSH peroxidase, and increased neuronal GSH levels. The neuroprotective effects of NA were partially blocked by co-treatment with an antagonist of peroxisome proliferator activated receptors (PPARs), and replicated by incubation with a selective PPARdelta (PPARδ) agonist. NA also increased expression and activation of PPARδ. Together these data demonstrate that NA can protect neurons from Aβ-induced damage, and suggest that its actions may involve activation of PPARδ and increases in GSH production. |
---|---|
AbstractList | The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical neurons. Exposure to oligomeric amyloid beta (Aβ) 1‐42 peptide induced neuronal damage revealed by increased staining with fluorojade, and toxicity assessed by LDH release. Aβ‐dependent neuronal death did not involve neuronal expression of the inducible nitric oxide synthase 2 (NOS2), since Aβ did not induce nitrite production from neurons, LDH release was not reduced by co‐incubation with NOS2 inhibitors, and neurotoxicity was similar in wildtype and NOS2 deficient neurons. Co‐incubation with NA partially reduced Aβ‐induced neuronal LDH release, and completely abrogated the increase in fluorojade staining. Treatment of neurons with NA increased expression of γ‐glutamylcysteine ligase, reduced levels of GSH peroxidase, and increased neuronal GSH levels. The neuroprotective effects of NA were partially blocked by co‐treatment with an antagonist of peroxisome proliferator activated receptors (PPARs), and replicated by incubation with a selective PPARdelta (PPARδ) agonist. NA also increased expression and activation of PPARδ. Together these data demonstrate that NA can protect neurons from Aβ‐induced damage, and suggest that its actions may involve activation of PPARδ and increases in GSH production. The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical neurons. Exposure to oligomeric amyloid beta (Abeta) 1-42 peptide induced neuronal damage revealed by increased staining with fluorojade, and toxicity assessed by LDH release. Abeta-dependent neuronal death did not involve neuronal expression of the inducible nitric oxide synthase 2 (NOS2), since Abeta did not induce nitrite production from neurons, LDH release was not reduced by co-incubation with NOS2 inhibitors, and neurotoxicity was similar in wildtype and NOS2 deficient neurons. Co-incubation with NA partially reduced Abeta-induced neuronal LDH release, and completely abrogated the increase in fluorojade staining. Treatment of neurons with NA increased expression of gamma-glutamylcysteine ligase, reduced levels of GSH peroxidase, and increased neuronal GSH levels. The neuroprotective effects of NA were partially blocked by co-treatment with an antagonist of peroxisome proliferator activated receptors (PPARs), and replicated by incubation with a selective PPARdelta (PPARdelta) agonist. NA also increased expression and activation of PPARdelta. Together these data demonstrate that NA can protect neurons from Abeta-induced damage, and suggest that its actions may involve activation of PPARdelta and increases in GSH production. [PUBLICATION ABSTRACT] Abstract The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical neurons. Exposure to oligomeric amyloid beta (Aβ) 1‐42 peptide induced neuronal damage revealed by increased staining with fluorojade, and toxicity assessed by LDH release. Aβ‐dependent neuronal death did not involve neuronal expression of the inducible nitric oxide synthase 2 (NOS2), since Aβ did not induce nitrite production from neurons, LDH release was not reduced by co‐incubation with NOS2 inhibitors, and neurotoxicity was similar in wildtype and NOS2 deficient neurons. Co‐incubation with NA partially reduced Aβ‐induced neuronal LDH release, and completely abrogated the increase in fluorojade staining. Treatment of neurons with NA increased expression of γ‐glutamylcysteine ligase, reduced levels of GSH peroxidase, and increased neuronal GSH levels. The neuroprotective effects of NA were partially blocked by co‐treatment with an antagonist of peroxisome proliferator activated receptors (PPARs), and replicated by incubation with a selective PPARdelta (PPARδ) agonist. NA also increased expression and activation of PPARδ. Together these data demonstrate that NA can protect neurons from Aβ‐induced damage, and suggest that its actions may involve activation of PPARδ and increases in GSH production. The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical neurons. Exposure to oligomeric amyloid beta (A beta ) 1-42 peptide induced neuronal damage revealed by increased staining with fluorojade, and toxicity assessed by LDH release. A beta -dependent neuronal death did not involve neuronal expression of the inducible nitric oxide synthase 2 (NOS2), since A beta did not induce nitrite production from neurons, LDH release was not reduced by co-incubation with NOS2 inhibitors, and neurotoxicity was similar in wildtype and NOS2 deficient neurons. Co-incubation with NA partially reduced A beta -induced neuronal LDH release, and completely abrogated the increase in fluorojade staining. Treatment of neurons with NA increased expression of gamma -glutamylcysteine ligase, reduced levels of GSH peroxidase, and increased neuronal GSH levels. The neuroprotective effects of NA were partially blocked by co-treatment with an antagonist of peroxisome proliferator activated receptors (PPARs), and replicated by incubation with a selective PPARdelta (PPAR delta ) agonist. NA also increased expression and activation of PPAR delta . Together these data demonstrate that NA can protect neurons from A beta -induced damage, and suggest that its actions may involve activation of PPAR delta and increases in GSH production. The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical neurons. Exposure to oligomeric amyloid beta (Abeta) 1-42 peptide induced neuronal damage revealed by increased staining with fluorojade, and toxicity assessed by LDH release. Abeta-dependent neuronal death did not involve neuronal expression of the inducible nitric oxide synthase 2 (NOS2), since Abeta did not induce nitrite production from neurons, LDH release was not reduced by co-incubation with NOS2 inhibitors, and neurotoxicity was similar in wildtype and NOS2 deficient neurons. Co-incubation with NA partially reduced Abeta-induced neuronal LDH release, and completely abrogated the increase in fluorojade staining. Treatment of neurons with NA increased expression of gamma-glutamylcysteine ligase, reduced levels of GSH peroxidase, and increased neuronal GSH levels. The neuroprotective effects of NA were partially blocked by co-treatment with an antagonist of peroxisome proliferator activated receptors (PPARs), and replicated by incubation with a selective PPARdelta (PPARdelta) agonist. NA also increased expression and activation of PPARdelta. Together these data demonstrate that NA can protect neurons from Abeta-induced damage, and suggest that its actions may involve activation of PPARdelta and increases in GSH production. |
Author | Richardson, Jill C Kalinin, Sergey Madrigal, Jose L.M Feinstein, Douglas L |
Author_xml | – sequence: 1 fullname: Madrigal, Jose L.M – sequence: 2 fullname: Kalinin, Sergey – sequence: 3 fullname: Richardson, Jill C – sequence: 4 fullname: Feinstein, Douglas L |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19439827$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17854349$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1u1DAUhS1URKcDrwAREt0l-DeJkbpAI35VlQV0bTnOdZtRxh7spMw8RN8ZuzNQiRWWJVu-3zn3yucMnTjvAKGC4Iqk9XZdEd6QkhMhK4pxU2Hetm21e4IWfwsnaIExpSXDnJ6isxjXGJOa1-QZOiVNKzjjcoHur2AOfhv8BGYa7qDQ6fAuFt4WzgfdB3B6HBy8K8DaxKSKK27GedLTbQKhiHs33UIcYqFd_yC_09kiO2wh-N0Q_QaK1GIcLAQ9-fCHgr4IYGCbn3oYJ_0cPbV6jPDieC7R9ccPP1afy8tvn76s3l-WRkjRlpaJzlDaMVvXDWtIq6kmWACnHZWApRG2gV72rawB18bUTHeibjurTUMY79gSnR9801Q_Z4iT2gzRwDhqB36OimKBeS1kAl__A679HNKPZKYWgrC0l6g9QCb4GANYtQ3DRoe9IljlvNRa5VhUjkXlvNRDXmqXpC-P_nO3gf5ReAwoAW-OgI5GjzZoZ4b4yEnOZEubxF0cuF_DCPv_HkB9vVrlW9K_Ouit9krfhNTj-jvFhGGc7QVjvwGLWb9w |
CODEN | JONRA9 |
CitedBy_id | crossref_primary_10_1016_j_pbb_2008_02_011 crossref_primary_10_1007_s12272_010_1017_4 crossref_primary_10_1093_brain_awq362 crossref_primary_10_1111_j_1471_4159_2010_06622_x crossref_primary_10_1212_WNL_0000000000206736 crossref_primary_10_1016_j_brainres_2017_09_035 crossref_primary_10_1016_j_freeradbiomed_2022_01_022 crossref_primary_10_1016_j_dci_2019_103573 crossref_primary_10_1007_s00441_017_2649_1 crossref_primary_10_1186_1471_2350_11_162 crossref_primary_10_1016_j_neurobiolaging_2014_05_020 crossref_primary_10_1016_j_actbio_2023_01_014 crossref_primary_10_1016_j_neubiorev_2013_05_008 crossref_primary_10_1089_ars_2017_7111 crossref_primary_10_1016_j_neuropharm_2018_08_003 crossref_primary_10_1016_j_nbd_2011_10_026 crossref_primary_10_1038_s41598_019_41756_3 crossref_primary_10_1016_j_nbd_2014_05_019 crossref_primary_10_1016_j_clnesp_2023_06_008 crossref_primary_10_3892_mmr_2018_8378 crossref_primary_10_1016_j_bbi_2018_01_004 crossref_primary_10_1016_j_neuint_2019_104531 crossref_primary_10_1016_j_brainres_2017_12_027 crossref_primary_10_1016_j_neurobiolaging_2019_09_014 crossref_primary_10_1007_s00401_020_02248_1 crossref_primary_10_1016_j_psychres_2013_08_035 crossref_primary_10_3389_fphar_2022_1030609 crossref_primary_10_1111_jnc_13447 crossref_primary_10_1007_s11064_011_0680_2 crossref_primary_10_1016_j_neuint_2013_06_012 crossref_primary_10_1111_j_1471_4159_2012_07673_x crossref_primary_10_1177_0960327112446840 crossref_primary_10_1016_j_neurobiolaging_2020_12_019 crossref_primary_10_1007_s11682_022_00653_6 crossref_primary_10_1007_s12640_016_9643_3 crossref_primary_10_1155_2013_253210 crossref_primary_10_3390_ijms13045074 crossref_primary_10_3390_ph14040339 crossref_primary_10_1177_1759091418784357 crossref_primary_10_1016_j_npep_2014_11_003 crossref_primary_10_1007_s11011_016_9800_7 crossref_primary_10_1016_j_bbadis_2013_03_006 crossref_primary_10_1016_j_brainresbull_2024_110907 crossref_primary_10_1007_s11064_015_1703_1 crossref_primary_10_1007_s11481_009_9182_2 crossref_primary_10_1186_s40478_017_0411_2 crossref_primary_10_1016_j_bbi_2021_02_030 crossref_primary_10_1155_2008_780452 crossref_primary_10_1016_j_neurobiolaging_2011_04_012 crossref_primary_10_1016_j_neuroscience_2017_12_046 crossref_primary_10_1073_pnas_0909586107 crossref_primary_10_1002_cne_22242 crossref_primary_10_1016_j_ceca_2011_09_002 crossref_primary_10_1016_j_preteyeres_2014_06_001 crossref_primary_10_3233_JAD_190090 crossref_primary_10_1038_s41390_018_0045_5 crossref_primary_10_3389_fneur_2020_00371 crossref_primary_10_1155_2011_373560 crossref_primary_10_1186_1742_2094_7_94 crossref_primary_10_1097_BRS_0b013e3182276d88 crossref_primary_10_1016_j_neulet_2010_01_046 crossref_primary_10_1155_2021_8881770 crossref_primary_10_14336_AD_2019_1125 crossref_primary_10_1038_npp_2011_42 |
Cites_doi | 10.1007/PL00005296 10.1523/JNEUROSCI.22-07-02434.2002 10.1002/jnr.20153 10.1016/j.bbalip.2007.04.018 10.1089/ars.2006.8.873 10.1002/jnr.20394 10.1021/bi0159581 10.1016/S0006-8993(03)02515-0 10.1016/S0891-0618(00)00041-7 10.1016/j.biochi.2004.11.010 10.1016/S0165-5728(99)00192-7 10.1016/0197-4580(95)00066-N 10.1523/JNEUROSCI.5186-05.2006 10.1016/S0736-5748(00)00017-4 10.1002/jnr.20877 10.1046/j.1471-4159.1994.62010372.x 10.1210/mend.14.12.0575 10.1111/j.1471-4159.1993.tb13425.x 10.1124/mol.104.007864 10.1016/j.neuroscience.2006.06.056 10.1111/j.1471-4159.1993.tb13658.x 10.1073/pnas.97.24.13390 10.1089/ars.2006.8.885 10.1016/j.ab.2005.06.010 10.1002/9780470123195.ch7 10.1523/JNEUROSCI.20-18-06862.2000 10.1016/j.brainresrev.2004.02.002 10.1016/S0006-8993(02)03773-3 10.1023/A:1025084415833 10.1523/JNEUROSCI.4042-03.2004 10.1016/j.neurobiolaging.2006.06.003 10.1016/S0140-6736(81)92657-X 10.1016/j.bcp.2005.03.033 10.1111/j.1365-2990.1983.tb00320.x 10.1126/science.2474201 10.1016/j.bbadis.2006.03.002 10.1128/MCB.20.14.5119-5128.2000 10.1016/S0092-8674(00)81664-5 10.1016/j.brainres.2005.12.061 10.1046/j.1471-4159.2001.00556.x 10.1124/jpet.106.115758 10.1128/MCB.20.24.9356-9363.2000 10.1111/j.1460-9568.2005.04427.x 10.1210/me.2002-0020 10.1053/meta.2001.19415 10.1016/0197-4580(95)80002-9 10.1038/sj.jcbfm.9600233 10.1007/s00702-005-0352-y 10.1097/00001756-200007140-00045 10.1271/bbb.61.1646 10.1046/j.1471-4159.2002.01210.x 10.1016/S0196-9781(02)00085-2 10.1016/S0197-0186(02)00049-9 10.1002/jnr.20481 10.1046/j.1471-4159.2003.01909.x 10.1016/0304-3940(93)90135-8 10.1523/JNEUROSCI.21-04-01179.2001 10.1124/mol.64.3.578 10.1016/j.cardiores.2005.10.019 10.1126/science.286.5448.2358 10.1186/1742-2094-1-9 10.1074/jbc.M210207200 10.1023/B:NERE.0000014834.06405.af 10.1016/S0014-2999(02)02789-9 10.1016/S0021-9258(18)68191-8 10.1523/JNEUROSCI.5463-03.2004 10.1046/j.1471-4159.2003.02019.x 10.1097/00001756-199305000-00015 10.3109/00207459408986079 10.1161/01.CIR.0000097003.49585.5E 10.1046/j.1471-4159.2000.0751438.x 10.1523/JNEUROSCI.4998-04.2005 10.1523/JNEUROSCI.4236-05.2006 |
ContentType | Journal Article |
Copyright | 2008 INIST-CNRS 2007 The Authors Journal Compilation 2007 International Society for Neurochemistry |
Copyright_xml | – notice: 2008 INIST-CNRS – notice: 2007 The Authors Journal Compilation 2007 International Society for Neurochemistry |
DBID | FBQ IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 |
DOI | 10.1111/j.1471-4159.2007.04888.x |
DatabaseName | AGRIS Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Chemoreception Abstracts Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | Virology and AIDS Abstracts CrossRef Neurosciences Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1471-4159 |
EndPage | 2101 |
ExternalDocumentID | 1383858661 10_1111_j_1471_4159_2007_04888_x 17854349 19439827 JNC4888 US201300827353 |
Genre | article Research Support, U.S. Gov't, Non-P.H.S Journal Article |
GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29L 2WC 31~ 33P 36B 3SF 4.4 41~ 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAJUZ AANLZ AAONW AASGY AAVGM AAXRX AAYJJ AAZKR ABCQN ABCUV ABCVL ABEML ABHUG ABIVO ABLJU ABPTK ABPVW ABQWH ABWRO ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOD ACGOF ACIWK ACMXC ACNCT ACPOU ACPRK ACSCC ACSMX ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFVGU AFZJQ AGJLS AHEFC AI. AIACR AIAGR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FBQ FEDTE FIJ FUBAC FZ0 G-S G.N GAKWD GODZA GX1 H.X HF~ HH5 HVGLF HZI HZ~ IH2 IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TWZ UB1 V8K VH1 W8V W99 WBKPD WIH WIJ WIK WIN WNSPC WOHZO WOW WQJ WRC WUP WXI WXSBR WYISQ X7M XG1 XJT YFH YNH YOC YUY ZA5 ZGI ZXP ZZTAW ~IA ~KM ~WT AHBTC AITYG HGLYW OIG 08R AAUGY IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 |
ID | FETCH-LOGICAL-c5958-f35bc22b3f6673718a2a105e42b29e09c5f7ed9d896e06cc63ab568bfac7134b3 |
IEDL.DBID | DR2 |
ISSN | 0022-3042 |
IngestDate | Wed Jul 24 11:49:06 EDT 2024 Thu Oct 10 22:26:28 EDT 2024 Fri Aug 23 01:53:18 EDT 2024 Sun Jul 28 07:06:41 EDT 2024 Sun Oct 22 16:07:46 EDT 2023 Sat Aug 24 00:53:19 EDT 2024 Wed Dec 27 19:27:42 EST 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Peptides Rat Alzheimer disease Toxicity Activation Endogenous Primary culture Degenerative disease Alzheimer's disease Release Peroxisome proliferator activated receptor Glutathione Nervous system diseases Enzyme Rodentia Beta-Amyloid Nitric-oxide synthase Cerebral disorder Vertebrata Mammalia Neuron PPARdelta Cell death Central nervous system disease Neurotransmitter Oxidoreductases |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5958-f35bc22b3f6673718a2a105e42b29e09c5f7ed9d896e06cc63ab568bfac7134b3 |
Notes | http://dx.doi.org/10.1111/j.1471-4159.2007.04888.x ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2007.04888.x |
PMID | 17854349 |
PQID | 206551351 |
PQPubID | 31528 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_20504659 proquest_journals_206551351 crossref_primary_10_1111_j_1471_4159_2007_04888_x pubmed_primary_17854349 pascalfrancis_primary_19439827 wiley_primary_10_1111_j_1471_4159_2007_04888_x_JNC4888 fao_agris_US201300827353 |
PublicationCentury | 2000 |
PublicationDate | December 2007 |
PublicationDateYYYYMMDD | 2007-12-01 |
PublicationDate_xml | – month: 12 year: 2007 text: December 2007 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England – name: New York |
PublicationTitle | Journal of neurochemistry |
PublicationTitleAlternate | J Neurochem |
PublicationYear | 2007 |
Publisher | Oxford, UK : Blackwell Publishing Ltd Blackwell Publishing Ltd Blackwell |
Publisher_xml | – name: Oxford, UK : Blackwell Publishing Ltd – name: Blackwell Publishing Ltd – name: Blackwell |
References | 2002; 16 2003; 959 2006b; 26 2006b; 8 2001; 50 2004; 29 1993; 61 1993; 60 2000b; 20 2004; 24 1993; 161 1999; 286 2000a; 18 1983; 9 1988; 263 2006; 1762 2004; 1 1998; 358 2003; 278 2005; 22 1993; 4 2005; 67 1994; 62 2005; 25 2004; 77 2000; 18 2002; 41 2000; 14 2002; 83 2005; 344 2000; 11 2007; 1771 2006; 69 2006; 26 2000; 97 2006a; 28 1999; 99 1994; 79 2005; 70 2003; 86 2003; 87 2005; 79 1997; 61 2003; 458 2003; 975 1995; 16 1981; 1 2007; 320 2004; 45 2000; 20 2006; 8 2005; 87 2005; 81 1999; 100 2001; 21 2006; 113 2003; 108 2006; 84 1989; 245 2002; 23 2000; 75 2002; 22 2006; 142 1999; 73 2001; 79 2003; 64 2006a; 1073–1074 2003; 23 e_1_2_7_5_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_60_1 e_1_2_7_17_1 e_1_2_7_62_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_64_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_66_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_68_1 e_1_2_7_47_1 e_1_2_7_26_1 e_1_2_7_49_1 Shrieve D. C. (e_1_2_7_58_1) 1988; 263 e_1_2_7_73_1 e_1_2_7_50_1 e_1_2_7_71_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_52_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_54_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_56_1 e_1_2_7_37_1 e_1_2_7_39_1 e_1_2_7_6_1 e_1_2_7_4_1 e_1_2_7_8_1 e_1_2_7_18_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_61_1 e_1_2_7_2_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_63_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_65_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_67_1 e_1_2_7_48_1 e_1_2_7_69_1 e_1_2_7_27_1 e_1_2_7_29_1 Heneka M. T. (e_1_2_7_28_1) 2000; 20 e_1_2_7_72_1 e_1_2_7_51_1 e_1_2_7_70_1 e_1_2_7_30_1 e_1_2_7_53_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_55_1 e_1_2_7_74_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_57_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_59_1 e_1_2_7_38_1 |
References_xml | – volume: 458 start-page: 235 year: 2003 end-page: 241 article-title: Propentofylline protects beta‐amyloid protein‐induced apoptosis in cultured rat hippocampal neurons publication-title: Eur. J. Pharmacol. – volume: 84 start-page: 398 year: 2006 end-page: 408 article-title: Acetyl‐l‐carnitine‐induced up‐regulation of heat shock proteins protects cortical neurons against amyloid‐beta peptide 1‐42‐mediated oxidative stress and neurotoxicity: implications for Alzheimer’s disease publication-title: J. Neurosci. Res. – volume: 20 start-page: 9356 year: 2000 end-page: 9363 article-title: Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta publication-title: Mol. Cell. Biol. – volume: 161 start-page: 41 year: 1993 end-page: 44 article-title: Toxic effect of a beta‐amyloid peptide (beta 22‐35) on the hippocampal neuron and its prevention publication-title: Neurosci. Lett. – volume: 14 start-page: 1962 year: 2000 end-page: 1975 article-title: Activation of peroxisome proliferator‐activated receptors (PPARs) by their ligands and protein kinase A activators publication-title: Mol. Endocrinol. – volume: 113 start-page: 645 year: 2006 end-page: 657 article-title: Lack of glutathione peroxidase‐1 exacerbates Abeta‐mediated neurotoxicity in cortical neurons publication-title: J. Neural Transm. – volume: 67 start-page: 1882 year: 2005 end-page: 1891 article-title: The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low‐level oxidative stress publication-title: Mol. Pharmacol. – volume: 1 start-page: 9 year: 2004 article-title: Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin‐1beta production publication-title: J. Neuroinflammation – volume: 18 start-page: 167 year: 2000a end-page: 179 article-title: Temporal, regional, and cell‐specific changes of iNOS expression after intrastriatal microinjection of interferon gamma and bacterial lipopolysaccharide publication-title: J. Chem. Neuroanat. – volume: 22 start-page: 2434 year: 2002 end-page: 2442 article-title: Noradrenergic depletion potentiates beta ‐amyloid‐induced cortical inflammation: implications for Alzheimer’s disease publication-title: J. Neurosci. – volume: 142 start-page: 655 year: 2006 end-page: 660 article-title: Amyloid beta‐protein1‐42 increases cAMP and apolipoprotein E levels which are inhibited by beta1 and beta2‐adrenergic receptor antagonists in mouse primary astrocytes publication-title: Neuroscience – volume: 20 start-page: 5119 year: 2000 end-page: 5128 article-title: Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator‐activated receptor beta(delta) publication-title: Mol. Cell. Biol. – volume: 25 start-page: 2566 year: 2005 end-page: 2575 article-title: Beta‐amyloid‐stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors publication-title: J. Neurosci. – volume: 79 start-page: 700 year: 2005 end-page: 706 article-title: Gamma‐glutamylcysteine ethyl ester‐induced up‐regulation of glutathione protects neurons against Abeta(1‐42)‐mediated oxidative stress and neurotoxicity: implications for Alzheimer’s disease publication-title: J. Neurosci. Res. – volume: 286 start-page: 2358 year: 1999 end-page: 2361 article-title: Mediation by a CREB family transcription factor of NGF‐dependent survival of sympathetic neurons publication-title: Science – volume: 75 start-page: 1438 year: 2000 end-page: 1446 article-title: Overexpression of glutathione peroxidase increases the resistance of neuronal cells to Abeta‐mediated neurotoxicity publication-title: J. Neurochem. – volume: 26 start-page: 1343 year: 2006 end-page: 1354 article-title: Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice publication-title: J. Neurosci. – volume: 77 start-page: 240 year: 2004 end-page: 249 article-title: Effect of the peroxisome proliferator‐activated receptor beta activator GW0742 in rat cultured cerebellar granule neurons publication-title: J. Neurosci. Res. – volume: 41 start-page: 357 year: 2002 end-page: 365 article-title: Noradrenergic regulation of inflammatory gene expression in brain publication-title: Neurochem. Int. – volume: 81 start-page: 390 year: 2005 end-page: 396 article-title: Norepinephrine protects cortical neurons against microglial‐induced cell death publication-title: J. Neurosci. Res. – volume: 61 start-page: 1646 year: 1997 end-page: 1649 article-title: Antioxidant effects of dopamine and related compounds publication-title: Biosci. Biotechnol. Biochem. – volume: 28 start-page: 1206 year: 2006a end-page: 1214 article-title: Noradrenaline deficiency in brain increases beta‐amyloid plaque burden in an animal model of Alzheimer’s disease publication-title: Neurobiol. Aging – volume: 18 start-page: 347 year: 2000 end-page: 358 article-title: Neuroprotective effects of estrogens: potential mechanisms of action publication-title: Int. J. Dev. Neurosci. – volume: 26 start-page: 3345 year: 2006 end-page: 3356 article-title: System Xc‐ and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid‐beta peptide 1–40 publication-title: J. Neurosci. – volume: 70 start-page: 177 year: 2005 end-page: 188 article-title: Receptor‐independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key? publication-title: Biochem. Pharmacol. – volume: 263 start-page: 14107 year: 1988 end-page: 14114 article-title: Heterogeneity of cellular glutathione among cells derived from a murine fibrosarcoma or a human renal cell carcinoma detected by flow cytometric analysis publication-title: J. Biol. Chem. – volume: 16 start-page: 2793 year: 2002 end-page: 2801 article-title: Identification of a functional peroxisome proliferator‐activated receptor response element in the rat catalase promoter publication-title: Mol. Endocrinol. – volume: 41 start-page: 6640 year: 2002 end-page: 6650 article-title: Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662 publication-title: Biochemistry – volume: 87 start-page: 522 year: 2003 end-page: 531 article-title: Activation of stimulatory heterotrimeric G proteins increases glutathione and protects neuronal cells against oxidative stress publication-title: J. Neurochem. – volume: 21 start-page: 1179 year: 2001 end-page: 1188 article-title: Beta‐amyloid stimulation of microglia and monocytes results in TNFalpha‐dependent expression of inducible nitric oxide synthase and neuronal apoptosis publication-title: J. Neurosci. – volume: 64 start-page: 578 year: 2003 end-page: 586 article-title: Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal/glial mesencephalic cultures requires the repression of presumptive astrocytes publication-title: Mol. Pharmacol. – volume: 60 start-page: 1945 year: 1993 end-page: 1948 article-title: Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures publication-title: J. Neurochem. – volume: 45 start-page: 38 year: 2004 end-page: 78 article-title: Noradrenergic mechanisms in neurodegenerative diseases: a theory publication-title: Brain Res. Brain Res. Rev. – volume: 50 start-page: 3 year: 2001 end-page: 11 article-title: The ligands/activators for peroxisome proliferator‐activated receptor alpha (PPARalpha) and PPARgamma increase Cu , Zn ‐superoxide dismutase and decrease p22phox message expressions in primary endothelial cells publication-title: Metabolism – volume: 16 start-page: 661 year: 1995 end-page: 674 article-title: Are reactive oxygen species involved in Alzheimer’s disease? publication-title: Neurobiol. Aging – volume: 20 start-page: 6862 year: 2000b end-page: 6867 article-title: Peroxisome proliferator‐activated receptor‐gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death publication-title: J. Neurosci. – volume: 320 start-page: 1087 year: 2007 end-page: 1096 article-title: Neuroprotective efficacy of the peroxisome proliferator‐activated receptor δ‐selective agonists and publication-title: J. Pharmacol. Exp. Ther. – volume: 16 start-page: 5 year: 1995 end-page: 10 article-title: Neurotoxicity of A beta amyloid protein is not altered by calcium channel blockade publication-title: Neurobiol. Aging – volume: 1073–1074 start-page: 460 year: 2006a end-page: 469 article-title: Peroxisome‐proliferator‐activated receptor‐gamma (PPARgamma) activation protects neurons from NMDA excitotoxicity publication-title: Brain Res. – volume: 1 start-page: 783 year: 1981 end-page: 784 article-title: Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia publication-title: Lancet – volume: 83 start-page: 973 year: 2002 end-page: 983 article-title: Microglia enhance beta‐amyloid peptide‐induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species publication-title: J. Neurochem. – volume: 358 start-page: 582 year: 1998 end-page: 585 article-title: Idebenone protects hippocampal neurons against amyloid beta‐peptide‐induced neurotoxicity in rat primary cultures publication-title: Naunyn Schmiedebergs Arch. Pharmacol. – volume: 24 start-page: 6799 year: 2004 end-page: 6809 article-title: Beta‐amyloid peptide at sublethal concentrations downregulates brain‐derived neurotrophic factor functions in cultured cortical neurons publication-title: J. Neurosci. – volume: 108 start-page: 2805 year: 2003 end-page: 2811 article-title: Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator‐activated receptor‐gamma agonist in hypercholesterolemia publication-title: Circulation – volume: 1771 start-page: 952 year: 2007 end-page: 960 article-title: Modulation of PPAR activity via phosphorylation publication-title: Biochim. Biophys. Acta – volume: 69 start-page: 440 year: 2006 end-page: 449 article-title: Peroxisome proliferator‐activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress‐induced apoptosis publication-title: Cardiovasc. Res. – volume: 62 start-page: 372 year: 1994 end-page: 375 article-title: Ca channel blockers attenuate beta‐amyloid peptide toxicity to cortical neurons in culture publication-title: J. Neurochem. – volume: 26 start-page: 811 year: 2006b end-page: 820 article-title: 15d‐Prostaglandin J2 activates peroxisome proliferator‐activated receptor‐gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats publication-title: J. Cereb. Blood Flow Metab. – volume: 24 start-page: 565 year: 2004 end-page: 575 article-title: Beta‐amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase publication-title: J. Neurosci. – volume: 29 start-page: 637 year: 2004 end-page: 650 article-title: Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress publication-title: Neurochem. Res. – volume: 87 start-page: 33 year: 2005 end-page: 38 article-title: Phosphorylation of PPARs: from molecular characterization to physiological relevance publication-title: Biochimie – volume: 99 start-page: 335 year: 1999 end-page: 345 article-title: PPARdelta is an APC‐regulated target of nonsteroidal anti‐inflammatory drugs publication-title: Cell – volume: 97 start-page: 13390 year: 2000 end-page: 13395 article-title: The neuroprotective effect of pituitary adenylate cyclase‐activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3‐related cysteine protease caspase‐3/CPP32 publication-title: Proc. Natl Acad. Sci. USA – volume: 1762 start-page: 575 year: 2006 end-page: 586 article-title: Anti‐amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer’s disease publication-title: Biochim. Biophys. Acta – volume: 975 start-page: 10 year: 2003 end-page: 21 article-title: Localization of PPARdelta in murine central nervous system: expression in oligodendrocytes and neurons publication-title: Brain Res. – volume: 278 start-page: 11612 year: 2003 end-page: 11622 article-title: characterization of conditions for amyloid‐beta peptide oligomerization and fibrillogenesis publication-title: J. Biol. Chem. – volume: 23 start-page: 625 year: 2003 end-page: 635 article-title: Intrinsic regulation of brain inflammatory responses publication-title: Cell. Mol. Neurobiol. – volume: 9 start-page: 3 year: 1983 end-page: 19 article-title: Pathological basis for neurotransmitter changes in Parkinson’s disease publication-title: Neuropathol. Appl. Neurobiol. – volume: 79 start-page: 200 year: 2001 end-page: 210 article-title: Noradrenaline provides long‐term protection to dopaminergic neurons by reducing oxidative stress publication-title: J. Neurochem. – volume: 100 start-page: 156 year: 1999 end-page: 168 article-title: Peroxisome proliferator‐activated receptor gamma agonists protect cerebellar granule cells from cytokine‐induced apoptotic cell death by inhibition of inducible nitric oxide synthase publication-title: J. Neuroimmunol. – volume: 245 start-page: 417 year: 1989 end-page: 420 article-title: Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease publication-title: Science – volume: 73 start-page: 209 year: 1999 end-page: 267 article-title: The enzymes of glutathione synthesis: gamma‐glutamylcysteine synthetase publication-title: Adv. Enzymol. Relat. Areas Mol. Biol. – volume: 344 start-page: 8 year: 2005 end-page: 15 article-title: Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands publication-title: Anal. Biochem. – volume: 61 start-page: 1565 year: 1993 end-page: 1568 article-title: Beta‐amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins publication-title: J. Neurochem. – volume: 8 start-page: 873 year: 2006b end-page: 883 article-title: Beta‐amyloid‐dependent expression of NOS2 in neurons: prevention by an alpha2‐adrenergic antagonist publication-title: Antioxid. Redox Signal. – volume: 86 start-page: 907 year: 2003 end-page: 916 article-title: Noradrenaline induces expression of peroxisome proliferator activated receptor gamma (PPARgamma) in murine primary astrocytes and neurons publication-title: J. Neurochem. – volume: 959 start-page: 328 year: 2003 end-page: 335 article-title: Prostaglandin E2 rescues cortical neurons from amyloid beta protein‐induced apoptosis publication-title: Brain Res. – volume: 22 start-page: 2199 year: 2005 end-page: 2206 article-title: Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta‐amyloid exposure publication-title: Eur. J. Neurosci. – volume: 79 start-page: 185 year: 1994 end-page: 190 article-title: The acute neurotoxic effect of beta‐amyloid on mature cultures of rat hippocampal neurons is attenuated by the anti‐oxidant U‐78517F publication-title: Int. J. Neurosci. – volume: 11 start-page: 2293 year: 2000 end-page: 2297 article-title: cAMP delays beta‐amyloid (25‐35) induced cell death in rat cortical neurons publication-title: Neuroreport – volume: 4 start-page: 523 year: 1993 end-page: 526 article-title: Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25–35 publication-title: Neuroreport – volume: 8 start-page: 885 year: 2006 end-page: 892 article-title: Effects of noradrenaline on neuronal NOS2 expression and viability publication-title: Antioxid. Redox Signal. – volume: 23 start-page: 1471 year: 2002 end-page: 1478 article-title: The neuropeptide PACAP attenuates beta‐amyloid (1‐42)‐induced toxicity in PC12 cells publication-title: Peptides – ident: e_1_2_7_31_1 doi: 10.1007/PL00005296 – ident: e_1_2_7_29_1 doi: 10.1523/JNEUROSCI.22-07-02434.2002 – ident: e_1_2_7_59_1 doi: 10.1002/jnr.20153 – ident: e_1_2_7_8_1 doi: 10.1016/j.bbalip.2007.04.018 – ident: e_1_2_7_36_1 doi: 10.1089/ars.2006.8.873 – ident: e_1_2_7_7_1 doi: 10.1002/jnr.20394 – ident: e_1_2_7_41_1 doi: 10.1021/bi0159581 – ident: e_1_2_7_69_1 doi: 10.1016/S0006-8993(03)02515-0 – ident: e_1_2_7_27_1 doi: 10.1016/S0891-0618(00)00041-7 – ident: e_1_2_7_14_1 doi: 10.1016/j.biochi.2004.11.010 – ident: e_1_2_7_26_1 doi: 10.1016/S0165-5728(99)00192-7 – ident: e_1_2_7_5_1 doi: 10.1016/0197-4580(95)00066-N – ident: e_1_2_7_55_1 doi: 10.1523/JNEUROSCI.5186-05.2006 – ident: e_1_2_7_23_1 doi: 10.1016/S0736-5748(00)00017-4 – ident: e_1_2_7_2_1 doi: 10.1002/jnr.20877 – ident: e_1_2_7_67_1 doi: 10.1046/j.1471-4159.1994.62010372.x – ident: e_1_2_7_40_1 doi: 10.1210/mend.14.12.0575 – ident: e_1_2_7_16_1 doi: 10.1111/j.1471-4159.1993.tb13425.x – ident: e_1_2_7_64_1 doi: 10.1124/mol.104.007864 – ident: e_1_2_7_32_1 doi: 10.1016/j.neuroscience.2006.06.056 – ident: e_1_2_7_9_1 doi: 10.1111/j.1471-4159.1993.tb13658.x – ident: e_1_2_7_66_1 doi: 10.1073/pnas.97.24.13390 – ident: e_1_2_7_45_1 doi: 10.1089/ars.2006.8.885 – ident: e_1_2_7_57_1 doi: 10.1016/j.ab.2005.06.010 – ident: e_1_2_7_24_1 doi: 10.1002/9780470123195.ch7 – volume: 20 start-page: 6862 year: 2000 ident: e_1_2_7_28_1 article-title: Peroxisome proliferator‐activated receptor‐gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.20-18-06862.2000 contributor: fullname: Heneka M. T. – ident: e_1_2_7_47_1 doi: 10.1016/j.brainresrev.2004.02.002 – ident: e_1_2_7_70_1 doi: 10.1016/S0006-8993(02)03773-3 – ident: e_1_2_7_21_1 doi: 10.1023/A:1025084415833 – ident: e_1_2_7_3_1 doi: 10.1523/JNEUROSCI.4042-03.2004 – ident: e_1_2_7_35_1 doi: 10.1016/j.neurobiolaging.2006.06.003 – ident: e_1_2_7_6_1 doi: 10.1016/S0140-6736(81)92657-X – ident: e_1_2_7_18_1 doi: 10.1016/j.bcp.2005.03.033 – ident: e_1_2_7_46_1 doi: 10.1111/j.1365-2990.1983.tb00320.x – ident: e_1_2_7_71_1 doi: 10.1126/science.2474201 – ident: e_1_2_7_49_1 doi: 10.1016/j.bbadis.2006.03.002 – ident: e_1_2_7_53_1 doi: 10.1128/MCB.20.14.5119-5128.2000 – ident: e_1_2_7_25_1 doi: 10.1016/S0092-8674(00)81664-5 – ident: e_1_2_7_73_1 doi: 10.1016/j.brainres.2005.12.061 – ident: e_1_2_7_65_1 doi: 10.1046/j.1471-4159.2001.00556.x – ident: e_1_2_7_34_1 doi: 10.1124/jpet.106.115758 – ident: e_1_2_7_43_1 doi: 10.1128/MCB.20.24.9356-9363.2000 – ident: e_1_2_7_15_1 doi: 10.1111/j.1460-9568.2005.04427.x – ident: e_1_2_7_22_1 doi: 10.1210/me.2002-0020 – ident: e_1_2_7_33_1 doi: 10.1053/meta.2001.19415 – ident: e_1_2_7_68_1 doi: 10.1016/0197-4580(95)80002-9 – ident: e_1_2_7_74_1 doi: 10.1038/sj.jcbfm.9600233 – ident: e_1_2_7_12_1 doi: 10.1007/s00702-005-0352-y – ident: e_1_2_7_51_1 doi: 10.1097/00001756-200007140-00045 – ident: e_1_2_7_72_1 doi: 10.1271/bbb.61.1646 – ident: e_1_2_7_54_1 doi: 10.1046/j.1471-4159.2002.01210.x – ident: e_1_2_7_50_1 doi: 10.1016/S0196-9781(02)00085-2 – ident: e_1_2_7_17_1 doi: 10.1016/S0197-0186(02)00049-9 – ident: e_1_2_7_44_1 doi: 10.1002/jnr.20481 – ident: e_1_2_7_37_1 doi: 10.1046/j.1471-4159.2003.01909.x – ident: e_1_2_7_61_1 doi: 10.1016/0304-3940(93)90135-8 – ident: e_1_2_7_11_1 doi: 10.1523/JNEUROSCI.21-04-01179.2001 – ident: e_1_2_7_48_1 doi: 10.1124/mol.64.3.578 – ident: e_1_2_7_52_1 doi: 10.1016/j.cardiores.2005.10.019 – ident: e_1_2_7_56_1 doi: 10.1126/science.286.5448.2358 – ident: e_1_2_7_13_1 doi: 10.1186/1742-2094-1-9 – ident: e_1_2_7_60_1 doi: 10.1074/jbc.M210207200 – ident: e_1_2_7_10_1 doi: 10.1023/B:NERE.0000014834.06405.af – ident: e_1_2_7_38_1 doi: 10.1016/S0014-2999(02)02789-9 – volume: 263 start-page: 14107 year: 1988 ident: e_1_2_7_58_1 article-title: Heterogeneity of cellular glutathione among cells derived from a murine fibrosarcoma or a human renal cell carcinoma detected by flow cytometric analysis publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)68191-8 contributor: fullname: Shrieve D. C. – ident: e_1_2_7_63_1 doi: 10.1523/JNEUROSCI.5463-03.2004 – ident: e_1_2_7_42_1 doi: 10.1046/j.1471-4159.2003.02019.x – ident: e_1_2_7_20_1 doi: 10.1097/00001756-199305000-00015 – ident: e_1_2_7_39_1 doi: 10.3109/00207459408986079 – ident: e_1_2_7_62_1 doi: 10.1161/01.CIR.0000097003.49585.5E – ident: e_1_2_7_4_1 doi: 10.1046/j.1471-4159.2000.0751438.x – ident: e_1_2_7_19_1 doi: 10.1523/JNEUROSCI.4998-04.2005 – ident: e_1_2_7_30_1 doi: 10.1523/JNEUROSCI.4236-05.2006 |
SSID | ssj0016461 |
Score | 2.22935 |
Snippet | The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact... Abstract The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact... |
SourceID | proquest crossref pubmed pascalfrancis wiley fao |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2092 |
SubjectTerms | Adult and adolescent clinical studies Alzheimer disease Alzheimer’s disease Amyloid beta-Peptides - toxicity Animals Beta-Amyloid Biological and medical sciences Brain Cell Survival - drug effects Cerebral Cortex Chemistry Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Embryo, Mammalian Fluoresceins Gene Expression Regulation - drug effects Glutamic Acid - metabolism Glutathione - metabolism L-Lactate Dehydrogenase - metabolism Medical sciences Mice Mice, Knockout Neurology neuron Neurons Neurons - drug effects Neuroprotective Agents Neurosciences Neurotransmitters Nitric Oxide Synthase Type II - deficiency Norepinephrine - pharmacology Organic Chemicals Organic mental disorders. Neuropsychology Peptide Fragments - toxicity PPAR delta - metabolism PPARdelta Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Rats Rodents Transfection - methods |
Title | Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1471-4159.2007.04888.x https://www.ncbi.nlm.nih.gov/pubmed/17854349 https://www.proquest.com/docview/206551351 https://search.proquest.com/docview/20504659 |
Volume | 103 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagF7jwaIGGQvEBccsqieM44VYtrMpK9ACs1Fs0flVVabIiu1LLf-A_M-MkW7bqASEuq2hjj2Lnm4cn82DsbQUVpF6ZOIFExHmWiliXpoi9wRk5VIkProHPJ8XxIp-fytMh_olyYfr6EBuHG3FGkNfE4KC7W0yu8PyD-nioRIhYLCdkT6ZCUXTXhy-bSlJURSvdFA5HoG4H9dxJaEtT3ffQUtwkdLh1vu95cZdRum3jBiU1e8wuxuX1sSkXk_VKT8zPW5Uf_8_6n7BHgy3Lj3rwPWX3XLPL9o4aPMdfXvN3PESXBrf9LnswHTvL7bFfoSLIUCECpS3vkys63nreICQpuRzoAd_zIdyEtw0_Qx6hUMm2cby7btBw7c47Do0N03vPMlGgyudX51176fiSWhJ5FyIJxlHOchTybkl_Wfd9Bc_YYvbx2_Q4HtpCxEZWsoy9kNpkmRaeWpaiboUM0Ep0eaazyiWVkV45W9myKlxSGFMI0LIotQdDibNaPGc7DT7rPuNWZ9oqCyJzqDEgBweiKEFbIUxpQUUsHSFQL_vqH_WfpyaV1rT_1MtT1WH_66uI7SNWajhDIV0vvmb0aRjtLCWkiNjhFoBuaFZoF-KYiB2MiKoHWdIh8YK68Mg0Ym82d_GN0ZcdaFy7piEyyQtZRexFD8Mbyqqk5GG8UwQw_fUy6vnJlK5e_uvEA_Yw-MFD6M8rtrP6sXav0YBb6cPAmvg7-zT_DUIlOns |
link.rule.ids | 315,783,787,1378,27938,27939,46308,46732 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWgHMqFjxZoKLQ-IG5ZJXHsJNyqhWop7R6gK_UWjR27qmiTFdmVWv4D_5kZJ9myVQ8IcVtt7FHivBmPJzNvGHtXQAGxy0wYQSTCNIlFqHOjQmdwRgpF5Hxo4GSqJrP06Eye9e2AqBam44dYBdxIM7y9JgWngPQdLc_wAIQbck9FiGDMR-hQPkLtF9TO4OPXFZcU8WjFK-pwhOp6Ws-9ktb2qocOGsqchBYXz3VdL-5zS9e9XL9NHT5ll8MDdtkp30fLhR6Zn3e4H__TCjxjT3p3lh90-HvOHth6i20f1HiUv7rh77lPMPWR-y22OR6ay22zX54UpCeJQIPLu_qKljeO14hKqi8HusMPvM844U3Nz1FNKFuyqS1vb2r0XduLlkNd-eldcJkkEPn59UXbXFk-p65EzvpkgmGUrTjaeTunvyp7uYAXbHb46XQ8CfvOEKGRhcxDJ6Q2SaKFo66luL1CAugo2jTRSWGjwkiX2aqo8kLZSBmjBGipcu3AUO2sFi_ZRo33usN4pRNdZRWIxOKmASlYECoHXQlh8gqygMUDBsp5RwBS_nlwyuKS1p_aeWalX__yOmA7CJYSztFOl7NvCX0dRlcrE1IEbG8NQbcyC3QNcUzAdgdIlb05aVG4okY8Mg7Y_uoqvjH6uAO1bZY0REapkkXAXnU4vJWc5VQ_jFeUR9NfP0Z5NB3Tr9f_OnGfbU5OT47L48_TL7vssQ-L-0ygN2xj8WNp36I_t9B7Xk9_A2ZuPZs |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5BkYALj5ZSU2j3gLg5sr322uZWpUSlQISASL1Zs6-qKrUjnEgt_4H_zMzaTknVA0Lconh3ZK_ntetvvmHsdQklxC7XYQSRCNMkFqEqtAydxhkplJHzRwOfpvJolh6fZCc9_olqYTp-iNWBG1mG99dk4HPjbhh5jvsfjMc9EyHqYjHCfPJeKkVE8K7DLysqKaLRilfM4aip66ieWyWthaq7DhoCTkKLa-e6phe3ZaXrSa6PUpPH7Hx4vg6ccj5aLtRI_7xB_fh_FuAJe9Qns_yg076n7I6tN9nWQY0b-Ysr_oZ7eKk_t99kD8ZDa7kt9stTgvQUEehueVdd0fLG8Rp1kqrLgW7wLe_xJryp-SkaCWElm9ry9qrGzLU9aznUxk_vjpZJAlGfX561zYXlc-pJ5KyHEgyjrOHo5e2c_jL2-wKesdnk3bfxUdj3hQh1VmZF6ESmdJIo4ahnKQZXSADTRJsmKiltVOrM5daUpiiljaTWUoDKZKEcaKqcVWKbbdR4rzuMG5UokxsQicWQASlYELIAZYTQhYE8YPGgAtW8o_-o_tw25XFF60_NPPPKr391GbAd1JUKTtFLV7OvCX0bxkQrF5kI2N6aAl3LLDExxDEB2x00quqdSYvCJbXhyeKA7a-u4hujTztQ22ZJQ7IolVkZsOedGl5LzguqHsYr0ivTXz9GdTwd068X_zpxn93_fDipPr6ffthlD_2ZuIcBvWQbix9L-wqTuYXa81b6G3NjPEo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neuroprotective+actions+of+noradrenaline%3A+effects+on+glutathione+synthesis+and+activation+of+peroxisome+proliferator+activated+receptor+delta&rft.jtitle=Journal+of+neurochemistry&rft.au=Madrigal%2C+Jose+L.M&rft.au=Kalinin%2C+Sergey&rft.au=Richardson%2C+Jill+C&rft.au=Feinstein%2C+Douglas+L&rft.date=2007-12-01&rft.pub=Oxford%2C+UK+%3A+Blackwell+Publishing+Ltd&rft.issn=0022-3042&rft.eissn=1471-4159&rft.volume=103&rft.issue=5&rft.spage=2092&rft.epage=2101&rft_id=info:doi/10.1111%2Fj.1471-4159.2007.04888.x&rft.externalDocID=US201300827353 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3042&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3042&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3042&client=summon |